plural feet play \ˈfēt\ also foot 2 : an invertebrate organ of locomotion or attachment; especially : a ventral muscular surface or process of a mollusc 3 : any of various units of length based on the length of the human foot; especially : a unit equal to 1⁄3 garden and comprising 12 inches plural foot used between a number and a noun plural feet or foot used between a number and an adjective — see weight table 4 : the basic unit of verse meter consisting of any of various fixed combinations or groups of stressed and unstressed or long and short syllables 5 a : motion or power of walking or running : step b : speed, swiftness 6 : something resembling a foot in position or use: as a : the lower end of the leg of a chair or table b 1 : the basal portion of the sporophyte in mosses 2 : a specialized outgrowth by which the embryonic sporophyte especially of many bryophytes absorbs nourishment from the gametophyte c : a piece on a sewing machine that presses the cloth against the feed 7 foot plural chiefly British : infantry 8 : the lower edge as of a sail 9 : the lowest part : bottom 10 a : the end that is lower or opposite the head b : the part as of a stocking that covers the foot 11 foots plural but sing or plural in constr : material deposited especially in ageing or refining : dregs
Currently, there are nearly 17 million people that suffer a stroke globally and more than two million stroke victims each year in the United States, Europe and Japan, combined. Ischemic strokes, which represent the most common form of stroke, are caused by a blockage of blood flow in the brain that cuts off the supply of oxygen and nutrients and can result in long-term or permanent disability due to neurological damage. http://www.upwoodybiomass.org/advisingeyedoctor/2016/09/21/if-the-tendonitis-has-caused-the-oily-liquid-that-protects-the-tendon-to-come-to-be-dry-this-can-be-listened-to-via-a-stethoscope-due-to-the-friction-inside-the-affected-area/Unfortunately, current therapeutic options for ischemic stroke victims are limited, since the only available therapies, administration of the clot dissolving agent tPA, or thrombolytic, or surgical intervention using mechanical reperfusion to remove the clot, must be conducted within several hours of the occurrence of the stroke. As a consequence of this limited time window, only a small percentage of stroke victims are treated with the currently available therapymost simply receive supportive or palliative care. The long-term costs of stroke are substantial, with many patients requiring extended hospitalization, extended physical therapy or rehabilitation (for those patients that are capable of entering such programs), and many require long-term institutional or family care. About MultiStem MultiStem cell therapy is a patented regenerative medicine product that has shown the ability to promote tissue repair and healing in a variety of ways, such as through the production of therapeutic factors produced in response to signals of inflammation and tissue damage. MultiStem therapys potential for multidimensional therapeutic impact distinguishes it from traditional biopharmaceutical therapies focused on a single mechanism of benefit. The product represents a unique “off-the-shelf” stem cell product that can be manufactured in a scalable manner, may be stored for years in frozen form, and is administered without tissue matching or the need for immune suppression. Based upon its efficacy profile, its novel mechanisms of action, and a favorable and consistent safety profile demonstrated in both preclinical and clinical settings, MultiStem therapy could provide a meaningful benefit to patients, including those suffering from serious diseases and conditions with unmet medical need. Athersys has forged strategic partnerships and a broad network of collaborations to develop MultiStem cell therapy for a variety of indications, with an initial focus in the neurological, cardiovascular and inflammatory and immune disorder areas. click for more infoAbout Athersys Athersys is an international biotechnology company engaged in the discovery and development of therapeutic product candidates designed to extend and enhance the quality of human life.
For the original version including any supplementary images or video, visit http://finance.yahoo.com/news/athersys-receives-fda-agreement-under-103000172.html
You may also be interested to read
- bottom of foot pain
- bunion hair tie